| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $137.0M | +45.7% |
| Cost of Revenue | $32.0M | +102.3% |
| R&D Expense | $44.9M | +51.5% |
| SG&A Expense | $143.0M | +64.9% |
| Operating Income | -$72.9M | -81.8% |
| Interest Expense | $17K | +1600.0% |
| Income Tax | -$1.8M | +79.7% |
| Net Income | -$67.1M | -114.6% |
| EPS (Basic) | -$2.58 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $122.9M | -62.7% |
| Accounts Receivable | $23.5M | +35.8% |
| Inventory | $4.0M | +96.9% |
| Current Assets | $292.3M | -17.4% |
| Total Assets | $447.3M | -3.3% |
| Current Liabilities | $36.1M | +45.2% |
| Total Liabilities | $48.2M | -5.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.7M | -119.4% |
| Capital Expenditures | $5.6M | +61.7% |
| Investing Cash Flow | -$166.5M | -149.9% |
| Financing Cash Flow | $1.5M | -72.1% |
| Free Cash Flow | -$47.3M | -110.5% |
| -108.1% |
| EPS (Diluted) | -$2.58 | -108.1% |
| Stockholders' Equity |
| $399.1M |
| -3.1% |